Home » Stocks » MLSS

Milestone Scientific, Inc. (MLSS)

Stock Price: $2.35 USD -0.10 (-4.08%)
Updated May 10, 2021 4:00 PM EDT - Market closed
Market Cap 149.98M
Revenue (ttm) 5.44M
Net Income (ttm) -7.34M
Shares Out 64.65M
EPS (ttm) -0.12
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day May 10
Last Price $2.35
Previous Close $2.45
Change ($) -0.10
Change (%) -4.08%
Day's Open 2.41
Day's Range 2.27 - 2.40
Day's Volume 247,118
52-Week Range 1.30 - 4.85

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Looking for penny stocks to watch in May? Look no further The post 4 Hot Penny Stocks To Watch In May 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Other stocks mentioned: AMS, PRPO, TOPS
6 days ago - PennyStocks

ROSELAND, N.J., May 03, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today...

1 week ago - GlobeNewsWire

Milestone Scientific Inc (NYSEAMERICAN:MLSS) posted fourth-quarter results on Thursday that saw its revenue rocket 78%, compared to the third quarter thanks to its growing dental business and flourishin...

1 month ago - Proactive Investors

Milestone Scientific Reports Continued Progress on Commercial Rollout of CompuFlo Epidural System Milestone Scientific Reports Continued Progress on Commercial Rollout of CompuFlo Epidural System

1 month ago - GlobeNewsWire

ROSELAND, N.J., March 30, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and pre...

1 month ago - GlobeNewsWire

Milestone Scientific, Inc. (MLSS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 month ago - Zacks Investment Research

ROSELAND, N.J., March 12, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provides virtually painl...

1 month ago - GlobeNewsWire

Milestone Scientific Inc (NYSEAMERICAN:MLSS) announced Wednesday it has received a Notice of Allowance from the European Patent Office as the company seeks to develop a device for ultrasound-guided peri...

2 months ago - Proactive Investors

ROSELAND, N.J., March 10, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and prec...

2 months ago - GlobeNewsWire

Milestone Scientific Inc (NYSEAMERICAN:MLSS), a leading developer of computerized drug delivery instruments that provide virtually painless and precise injections, said Tuesday it has begun selling Comp...

2 months ago - Proactive Investors

ROSELAND, N.J., March 02, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and prec...

2 months ago - GlobeNewsWire

Milestone Scientific Inc (NYSEAMERICAN:MLSS) announced Wednesday it had received a Notice of Allowance from the US patent office for its new CompuPulse System. The CompuPulse System integrates Milestone...

2 months ago - Proactive Investors

CompuPulse integrates CompuWave™ technology with a manual syringe to verify needle and catheter placement CompuPulse integrates CompuWave™ technology with a manual syringe to verify needle and catheter ...

2 months ago - GlobeNewsWire

Milestone Scientific Inc (NYSEAMERICAN:MLSS) said it has begun selling its CompuFloEpidural Instrument and related disposables to the University Hospital of Würzburg (UHW) in Germany. “We appreciate the...

2 months ago - Proactive Investors

ROSELAND, N.J., Feb. 23, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and preci...

2 months ago - GlobeNewsWire

Milestone Scientific Inc (NYSEAMERICAN:MLSS) reported that it has signed three additional distribution agreements in the US and one in Canada for the company's Wand Single Tooth Anesthesia (STA) System....

2 months ago - Proactive Investors

Brings network to eight independent North American distributors in under one month Brings network to eight independent North American distributors in under one month

2 months ago - GlobeNewsWire

ROSELAND, N.J., Feb. 12, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug instruments that provide painless and precise injections, announced tha...

2 months ago - GlobeNewsWire

Revolutionizing injections for doctors and patients CompuFlo instruments provide feedback to distinguish tissue types for precise location guidance Establishing relationships with world-class global par...

3 months ago - Proactive Investors

Milestone Scientific Inc (NYSEAMERICAN:MLSS) announced Tuesday that it has signed two additional distribution agreements with Atlanta Dental and Nashville Dental for its Wand Single Tooth Anesthesia (ST...

3 months ago - Proactive Investors

Adds four independent U.S. distributors in under one month

3 months ago - GlobeNewsWire

ROSELAND, N.J., Jan. 20, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and preci...

3 months ago - GlobeNewsWire

Agreements have been put into place with two distributors covering Florida, New York and New Jersey

3 months ago - GlobeNewsWire

ROSELAND, N.J., Jan. 06, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and preci...

4 months ago - GlobeNewsWire

Milestone's FDA approved CompuFlo and CathCheck instruments and disposables provide significant safety and economic benefits Milestone's FDA approved CompuFlo and CathCheck instruments and disposables p...

4 months ago - GlobeNewsWire

ROSELAND, N.J., Dec. 16, 2020 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and preci...

4 months ago - GlobeNewsWire

MLSS's dental business has almost fully recovered from the pandemic lows, with several tailwinds on the horizon. MLSS progressed its medical side of the business significantly in early Q4 with the annou...

5 months ago - Seeking Alpha

Anticipates over 40% sequential increase in sales for Q4 2020 versus Q3 2020 Anticipates over 40% sequential increase in sales for Q4 2020 versus Q3 2020

5 months ago - GlobeNewsWire

Milestone Scientific, Inc. (MLSS) CEO Leonard Osser on Q3 2020 Results - Earnings Call Transcript

5 months ago - Seeking Alpha

ROSELAND, N.J., Nov. 17, 2020 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, toda...

5 months ago - GlobeNewsWire

ROSELAND, N.J., Nov. 03, 2020 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, toda...

6 months ago - GlobeNewsWire

Interview features advantages of the CompuFlo® Epidural System and CathCheck™ Interview features advantages of the CompuFlo® Epidural System and CathCheck™

6 months ago - GlobeNewsWire

Agreement provides Premier’s 4,100 hospitals and 200,000 provider members with preferred access to CompuFlo® Epidural System and CathCheck™ Agreement provides Premier’s 4,100 hospitals and 200,000 provi...

6 months ago - GlobeNewsWire

MLSS has been hit hard by COVID-19, but their dental business has shown strong signs of recovery.

7 months ago - Seeking Alpha

ROSELAND, N.J., Oct. 01, 2020 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized drug delivery instruments that provides painless and precise inject...

7 months ago - GlobeNewsWire

Milestone Scientific, Inc. (MLSS) CEO Leonard Osser on Q2 2020 Results - Earnings Call Transcript

8 months ago - Seeking Alpha

Milestone Scientific, Inc. (MLSS) CEO Leonard Osser on Q1 2020 Results - Earnings Call Transcript

11 months ago - Seeking Alpha

Milestone Scientific Surges Again

1 year ago - Seeking Alpha

High-Risk, High-Reward Investors Should Love Milestone Scientific

1 year ago - Seeking Alpha

Milestone Scientific Inc. (MLSS) Q3 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

The company is using its profitable business for dental practices as a cash cow to develop its medical business.

1 year ago - Seeking Alpha

Milestone Scientific, Inc. (MLSS) CEO Leonard Osser on Q2 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Milestone Scientific Inc. (MLSS) CEO Len Osser on Q1 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Milestone Scientific Inc. (MLSS) on Q4 2018 Results - Earnings Call Transcript

2 years ago - Seeking Alpha

About MLSS

Milestone Scientific, Inc. develops computer-controlled anesthetic delivery devices for the medical and dental markets in the United States, China, and internationally. The company operates in two segments, Dental and Medical. Its products include CompuDent System that are used to control the flow rate of the anesthesia during the injection, which allows virtually painless injections for various dental procedures, including routine fillings, implants, root canals, and crowns. The company also offers CompuFlo, a computer-controlled drug delivery... [Read more...]

Industry
Medical Instruments & Supplies
IPO Date
Nov 3, 1995
Stock Exchange
NYSEAMERICAN
Ticker Symbol
MLSS
Full Company Profile

Financial Performance

In 2020, MLSS's revenue was $5.44 million, a decrease of -35.07% compared to the previous year's $8.37 million. Losses were -$7.34 million, -2.49% less than in 2019.

Financial Statements

Analyst Forecasts

According to one analyst, the rating for MLSS stock is "Buy" and the 12-month stock price forecast is 7.00.

Price Target
$7.00
Analyst Consensus: Buy